首页|凝血酶-抗凝血酶复合物、纤溶酶-α2-纤溶酶抑制剂复合物和血栓弹力图评估肿瘤患者凝血功能的价值

凝血酶-抗凝血酶复合物、纤溶酶-α2-纤溶酶抑制剂复合物和血栓弹力图评估肿瘤患者凝血功能的价值

Roles of TAT,PIC and thromboelastography for assessing coagulation function in tumor patients

扫码查看
目的 分析凝血酶-抗凝血酶复合物(TAT)、纤溶酶-α2-纤溶酶抑制剂复合物(PIC)和血栓弹力图(TEG)评估肿瘤患者凝血功能的价值.方法 选取2022年1月—2023年8月中国医学科学院肿瘤医院深圳医院120例肿瘤患者(病例组),以同期体检健康者30名作为对照组.比较2组TAT、PIC、TEG各参数的差异.基于Caprini评分将肿瘤患者细分为不同血栓风险组,比较各组TAT、PIC、TEG各参数的差异.比较不同肿瘤类型患者3项指标的差异.采用受试者工作特征(ROC)曲线分析TAT、PIC、TEG各参数诊断肿瘤患者凝血功能的效能.结果 病例组TAT、PIC高于对照组(P<0.05).血栓极高风险组TAT、PIC高于中/低风险组(P<0.05);肝癌、肺癌、肠癌、胃癌患者TAT、PIC水平均升高,但差异无统计学意义(P>0.05);TAT、PIC、TEG评价肿瘤患者血液高凝状态的敏感性分别为85.0%、55.0%、56.70%,特异性分别为93.3%、81.7%、70.0%,ROC曲线下面积分别为0.94、0.72、0.63.结论 TAT、PIC可早于TEG提示肿瘤患者凝血功能异常,能更好地提示肿瘤患者血液高凝状态.
Objective To analyze the roles of thrombin-antithrombin complex(TAT),plasmin-alpha 2-antiplasmin inhibitor complex(PIC)and thromboelastography(TEG)for assessing coagulation function in tumor patients.Methods A total of 120 tumor patients in Cancer Hospital and Shenzhen Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College from January 2022 to August 2023 were enrolled as case group,and 30 healthy subjects were enrolled as control group.The difference of TAT,PIC and TEG were compared.Caprini score was used to compare the differences of TAT,PIC and TEG for the patients with different thrombus risk,and the differences of TAT,PIC and TEG with different tumor types were compared.The efficacy of TAT,PIC and TEG in coagulation function of tumor patients was analyzed by receiver operating characteristic(ROC)curve.Results In case group,TAT and PIC were higher than those in control group(P<0.05).In thrombus extremely high-risk group,TAT and PIC were higher than those in medium/low-risk group(P<0.05).TAT and PIC in patients with liver cancer,lung cancer,colon cancer and gastric cancer were increased(P>0.05).The sensitivities of TAT,PIC and TEG in evaluating the hypercoagulable state of tumor patients were 85.0%,55.0%and 56.70%,and the specificities were 93.3%,81.7%and 70.0%,respectively.The areas under curves were 0.94,0.72 and 0.63,respectively.Conclusions TAT and PIC can determine abnormal coagulation function in tumor patients earlier than TEG,which can better indicate the hypercoagulabe state of tumor patients,and can be used as laboratory parameters for assessing coagulation function in tumor patients.

Thrombin-antithrombin complexPlasmin-alpha 2-antiplasmin inhibitor complexThromboelastographyCoagulation functionTumor

赖媛媛、何振业、沈化清、林一腾、刘熙君、齐军、林勇平

展开 >

国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院深圳医院检验科,广东 深圳 518116

华中科技大学协和深圳医院妇科,广东 深圳 518000

凝血酶-抗凝血酶复合物 纤溶酶-α2-纤溶酶抑制剂复合物 血栓弹力图 凝血功能 肿瘤

深圳市医疗卫生三名工程项目深圳市恶性肿瘤临床医学研究中心基金

SZSM201812062深科技创新[2021]287号

2024

检验医学
上海市临床检验中心

检验医学

CSTPCD
影响因子:1.715
ISSN:1673-8640
年,卷(期):2024.39(1)
  • 14